Prognostic value of the timing of immune checkpoint inhibitors infusion in patients with advanced hepatocellular carcinoma

被引:0
|
作者
Pascale, Alina [1 ]
Allard, Marc Antoine [2 ]
Benamar, Amal [1 ]
Levy, Francis [2 ]
Adam, Rene [2 ]
Rosmorduc, Olivier [3 ]
机构
[1] CHU Paul Brousse, AP HP, Villejuif, France
[2] Univ Paris Saclay, CHU Paul Brousse, AP HP, Villejuif, France
[3] Paris Sorbonne Univ, CHU Paul Brousse, AP HP, Villejuif, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
THU-491
引用
收藏
页码:S452 / S452
页数:1
相关论文
共 50 条
  • [21] Organ-specific differential responses to immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma
    Lu, Li-Chun
    Hsu, Chiun
    Shao, Yu-Yun
    Chao, Yee
    Yen, Chia-Jui
    Shih, I-Lun
    Hung, Yi-Ping
    Chang, Chun-Jung
    Shen, Ying-Chun
    Guo, Jhe-Cyuan
    Liu, Tsung-hao
    Hsu, Chih-Hung
    Cheng, Ann-Lii
    CANCER RESEARCH, 2018, 78 (13)
  • [22] Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Cowzer, D.
    Capanu, M.
    Keane, F.
    Khalil, D.
    Shia, J.
    Do, R.
    Chou, J.
    Walch, H.
    El Dika, I.
    Yaqubie, A.
    Solit, D.
    Berger, M.
    O'Reilly, E.
    Harding, J.
    Abou-Alfa, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S109 - S109
  • [23] Surrogate end points for survival in patients with advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
    Zhu, Andrew X.
    Lin, Yong
    Ferry, David
    Widau, Ryan C.
    Saha, Abhijoy
    IMMUNOTHERAPY, 2022, 14 (16) : 1341 - 1351
  • [24] Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score
    Li, Yongjiang
    Pan, Yangxun
    Lin, Ximeng
    Hou, Jingyu
    Hu, Zili
    Xu, Li
    Zhou, Zhongguo
    Zhang, Yaojun
    Chen, Minshan
    Hu, Dandan
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [25] Predictive and Prognostic Value of CTC Monitoring in Advanced NSCLC Patients Treated with Immune Checkpoint Inhibitors
    Gao, G.
    Li, J.
    Zhou, F.
    Li, W.
    Xiong, A.
    Chen, X.
    Ren, S.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S730 - S730
  • [26] Association of the pretreatment lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced hepatocellular carcinoma
    Sun, Tao
    Guo, Yusheng
    Sun, Bo
    Chen, Lei
    Ren, Yanqiao
    Zhu, Licheng
    Zhang, Lijie
    Liu, Yiming
    Zheng, Chuansheng
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [27] Association of the pretreatment lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced hepatocellular carcinoma
    Tao Sun
    Yusheng Guo
    Bo Sun
    Lei Chen
    Yanqiao Ren
    Licheng Zhu
    Lijie Zhang
    Yiming Liu
    Chuansheng Zheng
    European Journal of Medical Research, 28
  • [28] Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors
    Chawla, Neal S.
    Sayegh, Nicolas
    Tripathi, Nishita
    Govindarajan, Ameish
    Zengin, Zeynep B.
    Phillip, Errol J.
    Dizman, Nazli
    Meza, Luis
    Muddasani, Ramya
    Chehrazi-Raffle, Alexander
    Malhotra, Jasnoor
    Hsu, JoAnn
    Agarwal, Neeraj
    Pal, Sumanta K.
    Tripathi, Abhishek
    CLINICAL GENITOURINARY CANCER, 2023, 21 (01) : 69 - 75
  • [29] Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
    Ng, Kennedy Yao Yi
    Tan, Sze Huey
    Tan, Jack Jie En
    Tay, Desiree Shu Hui
    Lee, Ailica Wan Xin
    Ang, Andrea Jing Shi
    Wong, Lawrence Wen Jun
    Choo, Su Pin
    Tai, David Wai-Meng
    Lee, Joycelyn Jie Xin
    LIVER CANCER, 2022, 11 (01) : 9 - 21
  • [30] Immune Checkpoint Inhibitors in Combinations for Hepatocellular Carcinoma
    Kalasekar, Sharanya Maanasi
    Garrido-Laguna, Ignacio
    Evason, Kimberley Jane
    HEPATOLOGY, 2021, 73 (06) : 2591 - 2593